Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review
Open Access
Abstract
Background: Keratinocyte carcinomas, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), presents a growing concern. Electrochemotherapy (ECT), an emerging treatment modality, combines chemotherapy and electroporation to enhance drug delivery into cells. However, reviews evaluating ECT in keratinocyte carcinomas are lacking. Objectives: This study reviews the efficacy and toxicity of ECT in the treatment and palliation of keratinocyte carcinomas. Methods: A systematic search was conducted across PubMed, Cochrane, Embase, and Scopus databases. Patient, tumor, and treatment characteristics, tumor response, long-term disease outcomes, and toxicity data were extracted. Quality of studies was assessed using validated tools. Primary endpoints included tumor response; secondary endpoints included long-term disease outcomes and toxicity. Results: Twenty-one studies were included. Complete response (CR) rates ranged from 50 to 100% and from 10 to 100% for BCC and SCC, respectively. OS rates ranged from 95 (14 months) to 100 (1 year) % and from 64 (1 year) to 85.1 (8.6 months) % for BCC and SCC, respectively. One-year local disease-free survival (LDFS) rates were 89% and 87% for BCC and SCC, respectively. For BCC, local progression-free survival (LPFS) rates were 96% (1 year), 90% (2 year), and 70% (5 year). For SCC, 1-year LPFS rates were 80% on a per-patient basis and 49% on a per-lesion basis. Conclusions: ECT is effective and tolerable in the treatment and palliation of keratinocyte carcinomas. Future studies should focus on improving reporting quality, optimizing treatment protocols, and investigating long-term outcomes.Keywords
This publication has 55 references indexed in Scilit:
- Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic reviewClinical & Experimental Metastasis, 2022
- Distribution of skin cancers of the head and neck according to anatomical subunitEuropean Archives of Oto-Rhino-Laryngology, 2021
- Nonsurgical Treatments for Nonmelanoma Skin CancerDermatologic Clinics, 2019
- Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary resultsHead & Neck, 2017
- Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysisCancer Immunology, Immunotherapy, 2016
- Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapyCancer Chemotherapy and Pharmacology, 2016
- Electroquimioterapia en metástasis cutáneas de melanoma: Experiencia en 31 casosActas Dermo-Sifiliograficas, 2015
- Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intentJournal of Surgical Oncology, 2013
- Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycinCancer, 1998
- Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEuropean Journal of Cancer and Clinical Oncology, 1991